SECURITIES AND EXCHANGE COMMISSION
                                   Washington, D.C. 20549

                                          FORM 8-K

                                       CURRENT REPORT

                           Pursuant to Section 13 or 15(d) of the
                              Securities Exchange Act of 1934

             Date of Report (Date of earliest event reported): January 20, 1999

                                  SIMS Communications, Inc.
                   (Exact name of registrant as specified in its charter)


           Delaware                    0-25474              65-0287558
(State or other jurisdiction of    (Commission            (I.R.S. Employer
 incorporation or organization)     File Number)          Identification No.)

                                  18001 Cowan, Suite C & D
                                 Irvine, California 92614
                          (Address of principal executive offices)
                                         (Zip Code)

                                      (949) 261-6665
                    (Registrant's telephone number, including area code)


                                           N/A
                    (Former name, former address and former fiscal year,
                               if changed since last report)




<PAGE>


Item 5.  Other Events

    In December, 1998, the Company filed an 8-K report (dated December 14, 1998)
which disclosed the issuance of shares of the Company's Series C Preferred Stock
and the issuance of shares of common stock in connection with the acquisition of
certain technology from MedCard Management Systems, Inc.

    Subsequent  to the filing of the  Company's  8-K report  dated  December 14,
1998, the Company issued additional shares of common stock and warrants.

    The following "as adjusted"  balance sheet of the Company as of November 30,
1998 reflects these transactions:

                                                               November 30, 1998
                          November 30, 1998       Adjustments     (as adjusted)
ASSETS:

Cash and cash equivalents      $558,000          737,109 (1), (5)   $1,295,109

Accounts receivables,
   less allowance for
   doubtful accounts            150,000                                150,000

Inventories                     511,000                                511,000

Prepaid expenses and
   other current assets         297,000                                297,000

Notes receivable,
   current portion              150,000                                150,000

Property and Equipment
net of accumulated depreciation  2,740,000                           2,740,000

Notes receivable                   415,000                             415,000

Patents, net of accumulated
amortization                       370,000                             370,000

Licensing Rights (MedCard)         794,000                             794,000

Goodwill                           923,000                             923,000

Other                              350,000             77,730 (3)      427,730
                                  ---------           ---------       ---------
   Total Assets                 $7,258,000           $814,839       $8,072,839
                                ==========           ========        ==========


<PAGE>

                                                              November 30, 1998
                          November 30, 1998     Adjustments     (as adjusted)

LIABILITIES:

Accounts payable and
  Accrued Expenses           $1,000,768         (26,250) (4)        974,518

Bank Line of credit             250,000                             250,000

Current obligations
under capital lease              88,000                              88,000

Current maturities
  of long term debt             639,000        (310,347) (2)        328,653

Notes Payable-Other             200,000                             200,000

Franchise deposits
  and deferred revenue          828,000                             828,000

Long term debt                  217,000                             217,000

Obligations under
  capital leases                470,000                             470,000
                                -------                             -------

            Total Liabilities 3,692,768                           3,356,171

STOCKHOLDERS' EQUITY
   Preferred Stock, Series A and B  125                                 125

   Preferred Stock, Series C        155                                 155

   Common Stock                     980          163 (1), (2)         1,143
                                                     (4), (5)

Additional Paid in Capital   26,018,972       1,151,273 (1)-(5)  27,170,245

Accumulated Deficit         (22,455,000)                        (22,455,000)
                            ------------                        ------------

Total Stockholders' Equity    3,565,232                           4,716,668
                               --------                           ---------

Total Liabilities and Stockholders'
Equity                       $7,258,000       $814,839           $8,072,839
                             ==========       ========           ==========

<PAGE>


(1) Reflects  sale of 883,349  shares of common  stock and 176,670  warrants for
    $530,010,  less related offering expenses. Each warrant allows the holder to
    purchase  one  additional  share of common  stock at a price of  $1.54.  The
    exercise price of the warrants is 105% of the closing price of the Company's
    common stock on the date the shares of common stock were sold.

(2) Reflects   issuance  of  310,347  shares  of  Company's  common  stock  upon
    conversion of notes payable.

(3) Reflects  issuance of warrants to investment  banker.  Value of warrants has
    been computed using Black-Scholes option pricing model.

(4) Reflects  issuance  of  20,000  shares  of  Company's  common  stock  for
    services.

(5) Reflects  proceeds of notes payable  (December 28 and 29, 1998) and issuance
    of  423,728  shares of  Company's  common  stock  upon  conversion  of notes
    payable.

Financial Statements

The accompanying  unaudited consolidated financial statements have been prepared
in  accordance  with  generally  accepted  accounting   principles  for  interim
financial  information  and give  effect to the sale of the  Company's  Series C
Preferred  Stock and the issuance of shares of common stock in  connection  with
the MedCard transaction.

Item 7.  Financial Statements and Exhibits

No exhibits are filed with this report.

                                  SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

DATE: January 20, 1999
                                       SIMS COMMUNICATIONS, INC.

                                       By /s/ Mark Bennett
                                         -----------------------------
                                         Mark Bennett, President
[{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 7199}]
{"company-data": {"conformed-name": "SIMS COMMUNICATIONS INC", "cik": "0000907127", "assigned-sic": "4813", "irs-number": "650287558", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-25474", "film-number": "99509014"}, "business-address": {"street1": "18001 COWAN", "street2": "SUITE C & D", "city": "IRVINE", "state": "CA", "zip": "92614", "phone": "7142616665"}, "mail-address": {"street1": "17821 SKYPARK CIRCLE", "street2": "SUITE G", "city": "IRVINE", "state": "CA", "zip": "92614"}}
SECURITIES AND EXCHANGE COMMISSION
                                   Washington, D.C. 20549

                                          FORM 8-K

                                       CURRENT REPORT

                           Pursuant to Section 13 or 15(d) of the
                              Securities Exchange Act of 1934

             Date of Report (Date of earliest event reported): January 20, 1999

                                  SIMS Communications, Inc.
                   (Exact name of registrant as specified in its charter)

           Delaware                    0-25474              65-0287558
(State or other jurisdiction of    (Commission            (I.R.S. Employer
 incorporation or organization)     File Number)          Identification No.)

                                  18001 Cowan, Suite C & D
                                 Irvine, California 92614
                          (Address of principal executive offices)
                                         (Zip Code)

                                      (949) 261-6665
                    (Registrant's telephone number, including area code)

                                           N/A
                    (Former name, former address and former fiscal year,
                               if changed since last report)
Item 5.  Other Events

    In December, 1998, the Company filed an 8-K report (dated December 14, 1998)
which disclosed the issuance of shares of the Company's Series C Preferred Stock
and the issuance of shares of common stock in connection with the acquisition of
certain technology from MedCard Management Systems, Inc.

    Subsequent  to the filing of the  Company's  8-K report  dated  December 14,
1998, the Company issued additional shares of common stock and warrants.

    The following "as adjusted"  balance sheet of the Company as of November 30,
1998 reflects these transactions:

                                                               November 30, 1998
                          November 30, 1998       Adjustments     (as adjusted)
ASSETS:

Cash and cash equivalents      $558,000          737,109 (1), (5)   $1,295,109

Accounts receivables,
   less allowance for
   doubtful accounts            150,000                                150,000

Inventories                     511,000                                511,000

Prepaid expenses and
   other current assets         297,000                                297,000

Notes receivable,
   current portion              150,000                                150,000

Property and Equipment
net of accumulated depreciation  2,740,000                           2,740,000

Notes receivable                   415,000                             415,000

Patents, net of accumulated
amortization                       370,000                             370,000

Licensing Rights (MedCard)         794,000                             794,000

Goodwill                           923,000                             923,000

Other                              350,000             77,730 (3)      427,730
                                  ---------           ---------       ---------
   Total Assets                 $7,258,000           $814,839       $8,072,839
                                ==========           ========        ==========
November 30, 1998
                          November 30, 1998     Adjustments     (as adjusted)

LIABILITIES:

Accounts payable and
  Accrued Expenses           $1,000,768         (26,250) (4)        974,518

Bank Line of credit             250,000                             250,000

Current obligations
under capital lease              88,000                              88,000

Current maturities
  of long term debt             639,000        (310,347) (2)        328,653

Notes Payable-Other             200,000                             200,000

Franchise deposits
  and deferred revenue          828,000                             828,000

Long term debt                  217,000                             217,000

Obligations under
  capital leases                470,000                             470,000
                                -------                             -------

            Total Liabilities 3,692,768                           3,356,171

STOCKHOLDERS' EQUITY
   Preferred Stock, Series A and B  125                                 125

   Preferred Stock, Series C        155                                 155

   Common Stock                     980          163 (1), (2)         1,143
                                                     (4), (5)

Additional Paid in Capital   26,018,972       1,151,273 (1)-(5)  27,170,245

Accumulated Deficit         (22,455,000)                        (22,455,000)
                            ------------                        ------------

Total Stockholders' Equity    3,565,232                           4,716,668
                               --------                           ---------

Total Liabilities and Stockholders'
Equity                       $7,258,000       $814,839           $8,072,839
                             ==========       ========           ==========
(1) Reflects  sale of 883,349  shares of common  stock and 176,670  warrants for
    $530,010,  less related offering expenses. Each warrant allows the holder to
    purchase  one  additional  share of common  stock at a price of  $1.54.  The
    exercise price of the warrants is 105% of the closing price of the Company's
    common stock on the date the shares of common stock were sold.

(2) Reflects   issuance  of  310,347  shares  of  Company's  common  stock  upon
    conversion of notes payable.

(3) Reflects  issuance of warrants to investment  banker.  Value of warrants has
    been computed using Black-Scholes option pricing model.

(4) Reflects  issuance  of  20,000  shares  of  Company's  common  stock  for
    services.

(5) Reflects  proceeds of notes payable  (December 28 and 29, 1998) and issuance
    of  423,728  shares of  Company's  common  stock  upon  conversion  of notes
    payable.

Financial Statements

The accompanying  unaudited consolidated financial statements have been prepared
in  accordance  with  generally  accepted  accounting   principles  for  interim
financial  information  and give  effect to the sale of the  Company's  Series C
Preferred  Stock and the issuance of shares of common stock in  connection  with
the MedCard transaction.

Item 7.  Financial Statements and Exhibits

No exhibits are filed with this report.

                                  SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

DATE: January 20, 1999
                                       SIMS COMMUNICATIONS, INC.

                                       By /s/ Mark Bennett
                                         -----------------------------
                                         Mark Bennett, President